Yunxia Wang Selected Research

isonicotinamide

12/2022

HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunxia Wang Research Topics

Disease

20	Neoplasms (Cancer) 04/2022 - 08/2011
6	Inflammation (Inflammations) 01/2020 - 04/2009
5	Bacterial Infections (Bacterial Infection) 09/2020 - 10/2018
5	Infections 09/2020 - 04/2009
4	Abdominal Aortic Aneurysm 12/2022 - 01/2017
4	Wounds and Injuries (Trauma) 03/2020 - 07/2011
4	Myocardial Ischemia (Ischemic Heart Diseases) 11/2019 - 01/2008
4	Chronic Obstructive Pulmonary Disease (COPD) 05/2019 - 01/2018
4	Myotonia 07/2013 - 07/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2017
3	Lung Neoplasms (Lung Cancer) 06/2021 - 09/2017
3	Neoplasm Metastasis (Metastasis) 02/2020 - 01/2020
3	Disease Progression 01/2019 - 01/2015
3	Fibrosis (Cirrhosis) 08/2018 - 10/2014
3	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 10/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2021
2	Diabetes Mellitus 01/2021 - 01/2020
2	Pain (Aches) 01/2021 - 01/2008
2	Colonic Neoplasms (Colon Cancer) 02/2020 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2011
2	Body Weight (Weight, Body) 01/2020 - 01/2019
2	Atherosclerosis 01/2020 - 12/2019
2	Hypoxia (Hypoxemia) 01/2019 - 10/2014
2	Cholangiocarcinoma 01/2019 - 01/2016
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 01/2015
2	Non-alcoholic Fatty Liver Disease 11/2017 - 08/2017
2	Headache (Headaches) 03/2017 - 02/2017
2	Tuberculosis (Tuberculoses) 03/2016 - 08/2015
2	Rare Diseases (Rare Disease) 07/2013 - 10/2012
2	Neuralgia (Stump Neuralgia) 09/2011 - 09/2008
2	Leukemia 12/2002 - 11/2002
1	Rupture 12/2022
1	Oligomenorrhea 12/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Cholestasis 11/2021
1	Heart Failure 09/2021
1	Cardiotoxicity 09/2021
1	Carcinogenesis 06/2021
1	Hyperplasia 06/2021
1	Myocardial Infarction 01/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2021 - 05/2008
10	Pharmaceutical PreparationsIBA 12/2022 - 02/2008
9	Biomarkers (Surrogate Marker)IBA 04/2022 - 02/2014
7	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2013
5	PolymersIBA 03/2020 - 10/2018
5	Messenger RNA (mRNA)IBA 01/2019 - 01/2008
5	EnzymesIBA 04/2012 - 05/2008
4	Particulate MatterIBA 11/2019 - 01/2018
4	Sodium Channels (Sodium Channel)IBA 07/2013 - 07/2011
3	Circular RNAIBA 09/2021 - 11/2019
3	Purinergic P2X3 ReceptorsIBA 11/2019 - 05/2008
3	CollagenIBA 08/2018 - 01/2015
3	ARQ 197IBA 01/2018 - 11/2016
3	CytokinesIBA 03/2016 - 01/2015
2	naringeninIBA 12/2022 - 08/2017
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 08/2018
2	Therapeutic UsesIBA 01/2021 - 06/2018
2	VimentinIBA 02/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 02/2020 - 01/2015
2	Long Noncoding RNAIBA 02/2020 - 01/2020
2	Pancreatic Elastase (Elastase)IBA 01/2020 - 01/2017
2	PolyphenolsIBA 01/2020 - 01/2017
2	ElastinIBA 01/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2019
2	InflammasomesIBA 11/2019 - 08/2018
2	SmokeIBA 05/2019 - 01/2018
2	rasagiline (Azilect)FDA Link 01/2019 - 01/2015
2	Monoamine Oxidase (MAO)IBA 01/2019 - 01/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 07/2011
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 07/2011
2	Sirtuin 1IBA 01/2019 - 11/2017
2	cycloastragenolIBA 01/2019 - 08/2018
2	derazantinibIBA 01/2019 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 04/2009
2	Choline (Choline Chloride)IBA 08/2017 - 11/2015
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2008
2	SodiumIBA 07/2013 - 08/2011
2	ChloridesIBA 07/2013 - 07/2011
2	NAD (NADH)IBA 09/2011 - 12/2002
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2010 - 04/2009
2	Tryptophan (L-Tryptophan)FDA Link 02/2010 - 04/2009
2	A-317491IBA 05/2008 - 01/2008
1	isonicotinamideIBA 12/2022
1	Circulating Tumor DNAIBA 04/2022
1	Biocompatible Materials (Biomaterials)IBA 03/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	pirfenidoneIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022
1	InterleukinsIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021
1	Nucleic AcidsIBA 03/2021
1	Indicators and Reagents (Reagents)IBA 01/2021

Therapy/Procedure

13	Therapeutics 03/2022 - 08/2011
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2015
2	Endovascular Procedures 03/2017 - 02/2017
1	Length of Stay 12/2022
1	Acupressure (Shiatsu) 01/2021